STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population

Giacomo Canesin, Valentina Maggio, Macarena Palominos, Anna Stiehm, Hector R. Contreras, Enrique A. Castellón, Juan Morote, Rosanna Paciucci, Norman J. Maitland, Anders Bjartell, Rebecka Hellsten

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science